- (859) 323-3947
- Robert Straus Behavioral Science Laboratory
- 845 Angliana Avenue
- Lexington, KY 40508
PhD in Sociology, University of Georgia, 2003
In 2018, Dr. Knudsen continued to align her work with the Department of Behavioral Science’s tripartite mission of research, teaching, and service. Regarding research, Dr. Knudsen served as the Principal Investigator (PI) of a study on the impact of health reform on buprenorphine treatment through an R33 grant from the National Institute on Drug Abuse (NIDA). Dr. Knudsen also served as PI of a project on psychosocial supports in medication treatment for opioid use disorder through support from the Office of the Assistant Secretary for Planning and Evaluation (ASPE) in the US Department of Health and Human Services. In addition, she collaborated as a Co-Investigator on 6 NIH-funded studies: (1) the Kentucky JJ-TRIALS Substance Abuse and HIV Research Center, supported by NIDA (Dr. Carl Leukefeld, PI, University of Kentucky), (2) a NIDA-funded R01 on drug use in Appalachia (Dr. Jennifer Havens, PI, University of Kentucky), (3) a NIDA-funded R34 on improving re-entry outcomes for women with opioid use disorder (Dr. Michele Staton, PI, University of Kentucky, (4) a NIDA-funded R03 on the implementation of extended release naltrexone in prisons and offender reentry in Appalachia (Dr. Carrie Oser, PI, University of Kentucky), (5) a NIDA-funded R01 that seeks to disseminate substance use intervention recommendations to HIV/AIDS service organizations (Dr. Bryan Garner, PI, RTI International, and (6) a NIDA-funded R01 focused on strategies to increase the delivery of pharmacotherapy in substance use disorder (SUD) treatment programs in 3 states (Dr. Todd Molfenter, PI, University of Wisconsin). Dr. Knudsen also collaborated on an epidemiological study of medication-assisted treatment (Dr. Laura Dunlap, PI, RTI International) funded by the Centers for Disease Control and Prevention. In 2018, Dr. Knudsen had three papers appear in print, and four additional articles are in press. Dr. Knudsen presented her research at three national conferences. With regarding to teaching, in 2018, Dr. Knudsen served as a preceptor for MED811 (Introduction to Clinical Medicine). She continued to work as an Associate Director of the Ruth L. Kirchstein Institutional Training Grant on Drug Abuse Behavior, which is housed in the Department under the direction of Dr. Craig Rush. Dr. Knudsen also served as a member of five doctoral committees. Dr. Knudsen’s service activities encompassed involvement in scientific publishing, departmental service, and grant reviewing. Dr. Knudsen is Editor-in-Chief of Journal of Substance Abuse Treatment. This peer-reviewed journal receives about 400 submissions per year and is published monthly. She also reviewed manuscripts for Journal of Addiction Medicine, Substance Abuse Treatment, Prevention, and Policy, Psychiatric Services, Administration and Policy in Mental Health and Mental Health Services Research, and Addiction Science & Clinical Practice. For the Department of Behavioral Science’s Clinical and Translational Science programs, Dr. Knudsen served as the Director of Graduate Studies as well as a member of the Department’s Curriculum Committee. Finally, Dr. Knudsen served as a grant reviewer for NIH’s Center for Scientific Review and the National Institute on Drug Abuse, participating in three grant review meetings during 2018.
Dr. Knudsen’s research focuses on the addiction treatment system, both as organizational contexts for health care and as the workplaces of addiction counselors. Drawing on perspectives within implementation science, her recent work has focused on the organizational adoption of treatment innovations with an emphasis on the availability of pharmacotherapies within the American treatment system. Other recent publications have considered the types of managerial practices associated with burnout and turnover intention within this occupation and how work experiences influence counselors’ attitudes toward innovations. She is currently the Principal Investigator of a national study funded by the National Institute on Drug Abuse (NIDA) on the impact of the Affordable Care Act on the availability and quality of buprenorphine treatment for patients with opioid use disorders.
Principal Investigator, Buprenorphine Treatment and Health Reform: Availability, Utilization, and Quality, National Institute on Drug Abuse, 2013-2018.
Co-Investigator, Kentucky TRIALS Substance Abuse and HIV Research Center, National Institute on Drug Abuse, 2013-2018.
Associate Program Director, Research Training in Drug Abuse Behavior, National Institute on Drug Abuse, 2013-2018.
Co-Investigator, Adoption of Innovations in Private A&D Treatment Centers, National Institute on Drug Abuse, 2011-2016.
Co-Investigator, QuitAdvisorDDS: A Point of Care Tobacco Cessation Tool for Dental Settings, National Institute on Dental and Craniofacial Research, 2013-2016.
Co-Investigator, Criminal Justice Drug Abuse Treatment Studies (CJDATS-2) Central States Center, National Institute on Drug Abuse, 2008-2014.
Co-Investigator, Use of Evidence-Based Practices in Alcoholism Treatment, National Institute on Alcohol Abuse and Alcoholism, 2008-2014.
Principal Investigator, Barriers to the Adoption of Pharmacotherapies in Publicly Funded Substance Abuse Treatment: Policy Barriers and Access to Physicians, RobertWood Johnson Foundation, 2008-2012.
Principal Investigator, Smoking Cessation Practices in Community Treatment Programs, National Institute on Drug Abuse, 2006-2008.
Principal Investigator, Service Delivery and Use of Evidence-Based Treatment Practices in Adolescent Substance Abuse Treatment Settings, Robert Wood Johnson Foundation’s Substance Abuse Policy Research Program, 2005-2008.
Knudsen, H. K., & Roman, P. M. (2016). The diffusion of acamprosate for the treatment of alcohol use disorder: A national longitudinal study. Journal of Substance Abuse Treatment, 62, 62-67. NIHMS739753.
Knudsen, H. K., Lofwall, M. R., Havens, J. R., & Walsh, S. L. (2015). States’ implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence. Drug and Alcohol Dependence, 157, 36-43. NIHMS729346.
Knudsen, H. K., & Roman, P. M. (2015). Medicaid, private insurance, and the availability of smoking cessation interventions in substance use disorder treatment. Psychiatric Services, 66, 1213-1220. NIHMS695058.
Knudsen, H. K. (2015). The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: A state-level analysis. Journal of Studies on Alcohol and Drugs, 76, 644-654. PMC4495082.
Knudsen, H. K., & Roman, P. M. (2015). Innovation attributes and adoption decisions: Perspectives from leaders of a national sample of SUD organizations. Journal of Substance Abuse Treatment, 49, 1-7. PMC4277913.
Knudsen, H. K., Staton-Tindall, M., Oser, C. B., Havens, J. R., & Leukefeld, C. G. (2014). Reducing risky relationships: A multi-site randomized trial of a prison-based intervention for reducing HIV sexual risk behaviors among women with a history of drug use. AIDS Care, 26, 1071-1079. PMC4065193.
Knudsen, H. K., & Roman, P. M. (2014). Dissemination, adoption, and implementation of acamprosate for treating alcohol use disorders. Journal of Studies on Alcohol and Drugs, 75, 467-475. PMC4002860.
Knudsen, H. K, & Roman, P. M. (2014). The transition to medication adoption in publicly funded treatment substance use disorder treatment programs: Organizational structure, culture, and resources. Journal of Studies on Alcohol and Drugs, 75, 475-485. PMC4002861.
Knudsen, H. K., Muilenburg, J. L., & Eby, L. T. (2013). Sustainment of smoking cessation programs in substance use disorder treatment organizations. Nicotine & Tobacco Research, 15, 1060-1068. PMC3646650.
Knudsen, H. K., Roman, P. M., & Abraham, A. J. (2013). Quality of clinical supervision and counselor emotional exhaustion: The mediating roles of organizational and occupational commitment. Journal of Substance Abuse Treatment, 44, 528-533. PMC3602390.
Knudsen, H. K., & Abraham, A. J. (2012). The employment of nurses in publicly funded substance abuse treatment programs. Journal of Addictions Nursing, 23, 174-180. PMC3877938.
Knudsen, H. K., Abraham, A. J., Oser, C. B., & Roman, P. M. (2012). Physicians in the substance abuse treatment workforce: Understanding their employment within publicly funded treatment organizations. Journal of Substance Abuse Treatment, 43, 152-160. PMC3345304.